Evidence map›Paper›PMID 36006162›Full record

ArticleToxics2022

HBM4EU Chromates Study-Genotoxicity and Oxidative Stress Biomarkers in Workers Exposed to Hexavalent Chromium.

Ana Tavares, Kukka Aimonen, Sophie Ndaw, Aleksandra Fučić, Julia Catalán, Radu Corneliu Duca, Lode Godderis, Bruno C Gomes, Beata Janasik, Carina Ladeira and 12 more

Abstract read
In one paragraph

Article in Toxics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ana TavaresDepartment of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Kukka AimonenFinnish Institute of Occupational Health, 00250 Helsinki, Finland.
Sophie NdawFrench National Research and Safety Institute, 54500 Vandœuvre-lès-Nancy, France.ORCID 0000-0002-7518-2465
Aleksandra FučićInstitute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10001 Zagreb, Croatia.
Julia CatalánFinnish Institute of Occupational Health, 00250 Helsinki, Finland.ORCID 0000-0003-2936-242X
Radu Corneliu DucaCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium.ORCID 0000-0002-9350-3816
Lode GodderisCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium.ORCID 0000-0003-4764-8835
Bruno C GomesCentre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal.ORCID 0000-0002-5632-1095
Beata JanasikDepartment of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland.
Carina LadeiraHTRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1549-020 Lisbon, Portugal.ORCID 0000-0001-5588-0074
Henriqueta LouroDepartment of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0001-9744-7332
Sónia NamoradoDepartment of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0002-7500-8811
An Van NieuwenhuyseCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium.
Hannu NorppaFinnish Institute of Occupational Health, 00250 Helsinki, Finland.ORCID 0000-0001-6637-904X
Paul T J ScheepersRadboud Institute for Health Sciences, Radboudumc, 6500 HB Nijmegen, The Netherlands.ORCID 0000-0002-8546-2161
Célia VenturaDepartment of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0002-0637-2222
Jelle VerdonckCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium.ORCID 0000-0002-4105-5126
Susana ViegasNOVA National School of Public Health, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal.ORCID 0000-0003-1015-8760
Wojciech WasowiczDepartment of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland.
Tiina SantonenFinnish Institute of Occupational Health, 00250 Helsinki, Finland.ORCID 0000-0002-8150-4985
Maria João SilvaDepartment of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0002-6060-0716
On Behalf Of The Hbm Eu Chromates Study Team

Funding

the European Union's Horizon 2020 research and innovation programme 733032
6 · The paper itself

Abstract

A study was conducted within the European Human Biomonitoring Initiative (HBM4EU) to characterize occupational exposure to Cr(VI). Herein we present the results of biomarkers of genotoxicity and oxidative stress, including micronucleus analysis in lymphocytes and reticulocytes, the comet assay in whole blood, and malondialdehyde and 8-oxo-2′-deoxyguanosine in urine. Workers from several Cr(VI)-related industrial activities and controls from industrial (within company) and non-industrial (outwith company) environments were included. The significantly increased genotoxicity (p = 0.03 for MN in lymphocytes and reticulocytes; p < 0.001 for comet assay data) and oxidative stress levels (p = 0.007 and p < 0.001 for MDA and 8-OHdG levels in pre-shift urine samples, respectively) that were detected in the exposed workers over the outwith company controls suggest that Cr(VI) exposure might still represent a health risk, particularly, for chrome painters and electrolytic bath platers, despite the low Cr exposure. The within-company controls displayed DNA and chromosomal damage levels that were comparable to those of the exposed group, highlighting the relevance of considering all industry workers as potentially exposed. The use of effect biomarkers proved their capacity to detect the early biological effects from low Cr(VI) exposure, and to contribute to identifying subgroups that are at higher risk. Overall, this study reinforces the need for further re-evaluation of the occupational exposure limit and better application of protection measures. However, it also raised some additional questions and unexplained inconsistencies that need follow-up studies to be clarified.

Indexed as

8-OHdGbiomonitoringchromatecomet assayeffect biomarkersMDAmicronucleioccupational exposure

Identifiers

PMID36006162
PMCPMC9412464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.